GLP-1 Rapid Access Care (GRACE) is a proposed model of opioid harm reduction that would provide immediate access to GLP-1RA craving reduction treatment for people with OUD without the obstacles to initiation of opioid agonist therapy (OAT) and without requiring abstinence. GRACE can bridge harm reduction and treatment and can be deployed in settings where medication for opioid use disorder (MOUD) treatment initiation has not traditionally been possible.